Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs NRG Energy Inc (NRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs NRG Energy Inc — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.32 (market cap $7.10B), while NRG Energy Inc trades at $98.7 (market cap $21.20B). The key difference: NRG Energy Inc is far larger — about 3× Ionis Pharmaceuticals Inc. Common Stock's market cap, and NRG Energy Inc pays a 1.88% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and NRG Energy Inc for 63 Days on average.
| IONS | NRG | |
|---|---|---|
Market Cap | $7.10B | $21.20B |
Volume | 2,027,457 | 2,487,856 |
Sector | Health | Utilities |
52-Week High | $86.50 | $184.03 |
52-Week Low | $42.38 | $95.23 |
Typical Hold Time | 0 Days | 63 Days |
Enterprise Value | $6.66B | $45.15B |
Dividend Yield | — | 1.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NRG Energy (NRG) trades at $107.18, up 0.76% on the day, with a neutral technical signal and mixed earnings history. Recent Q2 2026 results missed expectations, but revenue growth is projected to $33.1B in 2026. The company's 1.2 GW Texas data-center power project and LS Power acquisition are key growth drivers, though rising debt-to-asset ratio to 56.42% in 2025 signals financial leverage concerns. Analyst consensus remains strongly bullish with a $202.90 price target, supported by 70% buy ratings.
Outlook is cautiously optimistic given strong analyst support and strategic investments, but risks include execution challenges, high leverage, and volatile cash flows. The stock offers potential upside to consensus targets if growth initiatives deliver, yet investors face margin pressure and competitive threats in the utilities sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About NRG Energy Inc
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →
